How breast cancer treatment is planned
A breast cancer treatment plan is usually based on cancer stage, tumor size,
lymph node involvement, whether the cancer has spread, tumor grade, biomarker
status, overall health, and patient goals. Biomarkers such as estrogen receptor,
progesterone receptor, and HER2 can strongly influence treatment choices.
Treatment may be local, systemic, or both. Local treatments focus on the breast
or nearby area. Systemic treatments travel through the bloodstream and can affect
cancer cells throughout the body.
Neoadjuvant and adjuvant treatment
Treatment timing matters. Neoadjuvant treatment is given before the main treatment,
often to shrink a tumor before surgery. Adjuvant treatment is given after surgery
to lower the chance that cancer will return. Some patients may also receive
maintenance or long-term therapy depending on tumor type and risk.
1
Before surgery
Possible neoadjuvant chemotherapy, targeted therapy, hormone therapy, or other treatment.
2
Local treatment
Surgery, and sometimes radiation therapy depending on the case.
3
After surgery
Possible adjuvant radiation, chemotherapy, hormone therapy, targeted therapy, or immunotherapy.
4
Follow-up care
Monitoring, survivorship planning, symptom management, and long-term support.
Treatment side effects and supportive care
Side effects depend on the treatment type and the individual person. They may
include fatigue, pain, nausea, skin changes, hair loss, infection risk, lymphedema,
menopause-related symptoms, emotional distress, fertility concerns, or long-term
effects. Supportive care helps prevent, reduce, and manage symptoms during and
after treatment.
Important treatment safety note
This page is for general education only. Breast cancer treatment decisions must
be made with qualified healthcare professionals. Do not start, stop, delay, or
change treatment based on this page.